Mingming Yang
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Nanoparticle-Based Drug Delivery 2
-
- Cancer, Hypoxia, and Metabolism 1
- Co-authors
- Yifan Wang (5 shared papers)Weiye Deng (5 shared papers)Zhaogang Yang (5 shared papers)Wen Jiang (5 shared papers)Betty Y.S. Kim (2 shared papers)Chenliang Wang (2 shared papers)Yaqing Qie (1 shared paper)Andrew S. Lee (1 shared paper)
- Journals
- Frontiers in Pharmacology (2 papers)Journal of Clinical Investigation (1 paper)Dose-Response (1 paper)Translational Oncology (1 paper)JAMA Network Open (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Mingming Yang
15 papers receiving 701 citations
Mingming Yang's Hit Papers
Peers
Comparison fields: 5 of 67
- Genetics 109
- Cancer Research 111
- Biomaterials 89
- Immunology 138
- Oncology 115
Countries citing papers authored by Mingming Yang
This map shows the geographic impact of Mingming Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingming Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingming Yang more than expected).
Fields of papers citing papers by Mingming Yang
This network shows the impact of papers produced by Mingming Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingming Yang. The network helps show where Mingming Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingming Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 211 | |
| 2 | 2018 | 141 | |
| 3 | 2020 | 81 | |
| 4 | 2019 | 76 | |
| 5 | 2023 | 42 | |
| 6 | Hypoxic-Ischemic Encephalopathy: Pathogenesis and Promising Therapies Hit paper breakdown → | 2024 | 38 |
| 7 | 2020 | 29 | |
| 8 | 2021 | 27 | |
| 9 | 2021 | 22 | |
| 10 | 2022 | 16 | |
| 11 | 2025 | 14 | |
| 12 | 2023 | 5 | |
| 13 | 2020 | 3 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 1 |
About Mingming Yang
Mingming Yang is a scholar working on Biomaterials, Cancer Research, Oncology, Immunology and Neurology, having authored 15 papers that have together received 708 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Genomics and Rare Diseases (1 paper), Neonatal and fetal brain pathology (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Cancer Cells and Metastasis (1 paper), Multiple and Secondary Primary Cancers (1 paper) and Pediatric Hepatobiliary Diseases and Treatments (1 paper). The work is most often cited by research in Genetics (109 citations), Cancer Research (111 citations), Biomaterials (89 citations), Immunology (138 citations) and Oncology (115 citations). Mingming Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yifan Wang, Weiye Deng, Zhaogang Yang, Wen Jiang, Betty Y.S. Kim, Chenliang Wang, Yaqing Qie, Andrew S. Lee, Chao Xing and Kyuson Yun. Their work appears in journals such as Frontiers in Pharmacology, Journal of Clinical Investigation, Dose-Response, Translational Oncology and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.